PRINCIPAL FINANCIAL GROUP INC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 238 filers reported holding BLUEBIRD BIO INC in Q1 2021. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q2 2024$28,131
-43.7%
28,583
-26.8%
0.00%
Q1 2024$49,954
+8.7%
39,026
+17.2%
0.00%
Q4 2023$45,955
-59.9%
33,301
-11.8%
0.00%
Q3 2023$114,733
-9.2%
37,741
-1.7%
0.00%
Q2 2023$126,306
+26.7%
38,391
+22.4%
0.00%
Q1 2023$99,716
-44.1%
31,357
+21.7%
0.00%
Q4 2022$178,266
+23.8%
25,761
+12.8%
0.00%
Q3 2022$144,000
+89.5%
22,832
+24.9%
0.00%
Q2 2022$76,000
+10.1%
18,274
+27.8%
0.00%
Q1 2022$69,000
-96.7%
14,297
-93.1%
0.00%
-100.0%
Q4 2021$2,072,000
-75.5%
207,382
-53.1%
0.00%
-83.3%
Q3 2021$8,457,000
-38.3%
442,564
+3.2%
0.01%
-33.3%
Q2 2021$13,717,000
+65.8%
428,934
+56.4%
0.01%
+50.0%
Q1 2021$8,271,000
+66.6%
274,337
+139.1%
0.01%
+50.0%
Q4 2020$4,964,000
-17.8%
114,723
+2.5%
0.00%
-20.0%
Q3 2020$6,041,000
-12.2%
111,970
-0.7%
0.01%
-16.7%
Q2 2020$6,882,000
+175.8%
112,755
+107.8%
0.01%
+100.0%
Q1 2020$2,495,000
-48.3%
54,271
-1.3%
0.00%
-25.0%
Q4 2019$4,823,000
-7.2%
54,971
-2.9%
0.00%
-20.0%
Q3 2019$5,199,000
-30.4%
56,624
-3.6%
0.01%
-28.6%
Q2 2019$7,471,000
+13.3%
58,730
+40.2%
0.01%
+16.7%
Q1 2019$6,592,000
+69.6%
41,896
+7.0%
0.01%
+50.0%
Q4 2018$3,886,000
-36.0%
39,172
-5.8%
0.00%
-20.0%
Q3 2018$6,069,000
-12.8%
41,564
-6.2%
0.01%
-16.7%
Q2 2018$6,956,000
-43.2%
44,317
-38.2%
0.01%
-50.0%
Q1 2018$12,252,000
-4.4%
71,753
-0.3%
0.01%0.0%
Q4 2017$12,816,000
+34.9%
71,964
+4.0%
0.01%
+33.3%
Q3 2017$9,503,000
+98.8%
69,185
+52.0%
0.01%
+80.0%
Q2 2017$4,781,000
+134.6%
45,503
+102.9%
0.01%
+150.0%
Q1 2017$2,038,000
+46.8%
22,425
-0.3%
0.00%0.0%
Q4 2016$1,388,000
-3.7%
22,499
+5.8%
0.00%0.0%
Q3 2016$1,442,000
+65.7%
21,270
+5.7%
0.00%
+100.0%
Q2 2016$870,000
-0.2%
20,116
-2.0%
0.00%0.0%
Q1 2016$872,000
-33.8%
20,5340.0%0.00%
-50.0%
Q4 2015$1,318,000
-25.1%
20,534
-0.2%
0.00%
-33.3%
Q3 2015$1,759,000
-59.6%
20,565
-20.5%
0.00%
-50.0%
Q2 2015$4,358,000
-28.5%
25,881
-48.7%
0.01%
-33.3%
Q1 2015$6,091,000
+33.2%
50,434
+1.1%
0.01%
+28.6%
Q4 2014$4,574,000
+141.1%
49,875
-5.6%
0.01%
+133.3%
Q3 2014$1,897,000
-5.9%
52,859
+1.1%
0.00%0.0%
Q2 2014$2,017,000
+72.5%
52,297
+1.7%
0.00%
+50.0%
Q1 2014$1,169,000
+9.5%
51,400
+1.0%
0.00%0.0%
Q4 2013$1,068,000
-20.8%
50,900
+1.8%
0.00%
-33.3%
Q3 2013$1,348,00050,0000.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q1 2021
NameSharesValueWeighting ↓
Casdin Capital, LLC 82,500$5,090,0004.20%
RTW INVESTMENTS, LP 122,576$7,563,0002.85%
Eventide Asset Management 587,677$36,260,0002.36%
First Light Asset Management, LLC 71,246$4,396,0001.93%
ARK Investment Management 75,645$4,667,0001.70%
Taylor Wealth Management Partners 39,118$2,414,0001.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 302,027$18,635,0000.77%
ARMISTICE CAPITAL, LLC 40,000$2,468,0000.58%
Artal Group S.A. 422,536$26,070,0000.58%
Baillie Gifford 5,164,467$318,647,0000.52%
View complete list of BLUEBIRD BIO INC shareholders